Biologics
May 18, 2012 at 19:30 | Source: Moneycontrol.com
Feb 23, 2012 at 10:22 | Source: Reuters
Feb 23, 2012 at 03:36 | Source: Reuters
Feb 06, 2012 at 15:34 | Source: Moneycontrol.com
Dec 29, 2011 at 20:06 | Source: PTI
Nov 01, 2011 at 09:46 | Source: Tech2.com
News across the web »
May 28, 2012 at 02:31 | Source: Forbes
May 26, 2012 at 22:27 | Source: DNA India
May 26, 2012 at 18:01 | Source: DNA India
May 26, 2012 at 18:00 | Source: Money Rediff News Report
May 26, 2012 at 12:50 | Source: DNA India
Interact & exchange stock tips & market info »
Related News »
ANN ARBOR, Mich., May 15, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, today reported financial results for the three ...
May 28, 2012 at 12:11 | Source: Yahoo Finance
LEXINGTON, Mass., May 22, 2012 /PRNewswire/ -- Avaxia Biologics, Inc., a privately-held biotechnology company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today that the company was awarded U.S ...
May 22, 2012 at 20:46 | Source: Genetic Engineering News
NEW YORK, May 15, 2012 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for ...
May 15, 2012 at 13:09 | Source: Marketwatch
ANN ARBOR, Mich., May 15, 2012 /PRNewswire via COMTEX/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, today reported financial results for the ...
May 15, 2012 at 18:24 | Source: CNBC
NEW YORK, May 15, 2012 (BUSINESS WIRE) -- Bristol-Myers Squibb Company (NYSE:BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved the company's biologics manufacturing facility in Devens, Massachusetts for commercial ...
May 15, 2012 at 14:57 | Source: CNBC
Startup Avalanche Biotechnologies Inc. and biologics manufacturer Lonza Group Ltd. Lonza Group Ltd. Latest from The Business Journals Two top execs depart Maryland Tech Council Human Genome Sciences readies lupus drug ahead of the FDA’s ...
May 16, 2012 at 19:35 | Source: The Business Journal
ANN ARBOR, Mich., May 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today the appointment of Carol Reed, M.D ...
May 13, 2012 at 23:56 | Source: 4-traders (press release)
RTP-based Heat Biologics said Tuesday that Heat CEO Jeffrey Wolf will take on an additional role: Heat president. That's because former president Taffy Williams is transitioning to a senior adviser role for Heat. Williams is the founder of ...
May 9, 2012 at 11:58 | Source: The Business Journal
(RTTNews) - Bristol-Myers Squibb Co. (BMY: News ) said Tuesday that the U.S. Food and Drug Administration has approved its biologics manufacturing facility in Devens, Massachusetts for commercial production of Orencia (abatacept). The Devens facility is a ...
May 15, 2012 at 16:30 | Source: RTT News